ClinVar

Description

The RAD51D p.Ser46Cys variant was identified in 1 of 1172 proband chromosomes (frequency: 0.0009) from individuals or families with unselected ovarian cancer or at high risk of breast cancer (and negative for breast and ovarian cancer genes); it was identified in an ovarian cancer case (Wickramanayake 2012). The variant was also identified in dbSNP (ID: rs587780102) “With Uncertain significance allele”, ClinVar (classified uncertain significance by GeneDx, Ambry Genetics, Invitae, ARUP Laboratories and Color Genomics Inc), and Clinvitae (3x), but was not identified in Cosmic and LOVD 3.0. The variant was identified in control databases in 25 of 276898 chromosomes at a frequency of 0.00009 (Genome Aggregation Database Feb 27, 2017). It was observed in the following populations: “Other” in 1 of 6464 chromosomes (freq: 0.0002), Latino in 4 of 34418 chromosomes (freq: 0.0001) and European Non-Finnish in 20 of 126540 chromosomes (freq: 0.0002); but not in the African, Ashkenazi Jewish, East Asian, European Finnish, and South Asian populations. The p.Ser46 residue is conserved in mammals but not in more distantly related organisms, and four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) suggest that the Cys variant may impact the protein; however, this information is not predictive enough to assume pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance.